LEADER 02781nam  2200601   450 
001 9910787375803321
005 20230120002206.0
010   $a0-12-405176-6
035   $a(CKB)3710000000341468
035   $a(OCoLC)900781265
035   $a(CaPaEBR)ebrary11011293
035   $a(SSID)ssj0001433100
035   $a(PQKBManifestationID)11995088
035   $a(PQKBTitleCode)TC0001433100
035   $a(PQKBWorkID)11413383
035   $a(PQKB)11744611
035   $a(MiAaPQ)EBC1929994
035   $a(Au-PeEL)EBL1929994
035   $a(CaPaEBR)ebr11011293
035   $a(CaONFJC)MIL708926
035   $a(EXLCZ)993710000000341468
100   $a20150205h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aClinical trial design challenges in mood disorders /$fedited by Mauricio Tohen [and three others]
210  1$aLondon, England :$cAcademic Press,$d2015.
210  4$dİ2015
215   $a1 online resource (192 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-322-77644-X 
311   $a0-12-405170-7 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aClinical trial design and maintenance treatments in bipolar disorder -- Meta-analysis of clinical trials in bipolar disorder -- Effectiveness trials in bipolar disorders -- Long-term treatment of mood disorders : follow-up of acute treatment phases studies versus continuation and maintenance phase studies, and enriched versus non-enriched designs -- The role of noninferiority designs in bipolar disorder clinical trials -- The use of mixed methods in drug discovery : integrating qualitative methods into clinical trials -- Sequential multiple assignment randomized treatment (SMART) : designs in bipolar disorder clinical trials -- Novel study designs for clinical trials in mood disorders -- Rating scales in bipolar disorder -- Clinical applicability of results from drug trials in bipolar disorder -- an attempt to shed light on a complex issue -- Clinical trials in developing countries : challenges in design, execution, and regulation.
606   $aAffective disorders
606   $aBipolar Disorder$xtherapy
606   $aMood Disorders$xtherapy
606   $aClinical Trials as Topic
615  0$aAffective disorders.
615 12$aBipolar Disorder$xtherapy.
615 22$aMood Disorders$xtherapy.
615 22$aClinical Trials as Topic.
676   $a616.8527
702   $aTohen$b Mauricio
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787375803321
996   $aClinical trial design challenges in mood disorders$93746998
997   $aUNINA

LEADER 01389aam  2200409I  450 
001 9910711234803321
005 20251201184252.0
024 8 $aGOVPUB-C13-816b79e8768a4e9482477811affc795f
035   $a(CKB)5470000002481675
035   $a(OCoLC)929064693
035   $a(EXLCZ)995470000002481675
100   $a20151113d1976      ua         0
101 0 $aeng
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aEvaluation, revision and application of the NBS stylus /$fE. C. Teague
210  1$aGaithersburg, MD :$cU.S. Dept. of Commerce, National Institute of Standards and Technology,$d1976.
215   $a1 online resource
225 1 $aNBS technical note ;$v902
300   $a1976.
300   $aContributed record: Metadata reviewed, not verified. Some fields updated by batch processes.
300   $aTitle from PDF title page.
320   $aIncludes bibliographical references.
606   $aMinicomputers$xProgramming
606   $aSurfaces
615  0$aMinicomputers$xProgramming.
615  0$aSurfaces.
700   $aTeague$b E. C$g(Edgar Clayton),$f1941-$01399064
712 02$aUnited States.$bNational Bureau of Standards.
801  0$bNBS
801  1$bNBS
801  2$bGPO
906   $aBOOK
912   $a9910711234803321
996   $aEvaluation, revision and application of the NBS stylus$93463690
997   $aUNINA